TITLE

Antineoplastics

PUB. DATE
October 2006
SOURCE
Reactions Weekly;10/21/2006, Issue 1124, p6
SOURCE TYPE
Periodical
DOC. TYPE
Case Study
ABSTRACT
The article presents the case of a 31-year-old man who developed telangiectasia after receiving antineoplastic therapy with doxorubicin, bleomycin, vinblastine and dacarbazine for Hodgkin's disease. It references a study by M. Rodríguez-Martín et al, published in the September 2006 issue of the "Journal of the European Academy of Dermatology and Venereology." Numerous dilated vessels in his upper and middle dermis were revealed by histopathological analysis.
ACCESSION #
23225628

 

Related Articles

  • Research & Markets: Brentuximab Vedotin - First Treatment Option for Relapsed Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma (Subset of Non-Hodgkin Lymphoma).  // Biomedical Market Newsletter;8/23/2011, Vol. 21, p77 

    The article discusses the need for drugs with enhanced toxicity and efficacy in treating Hodgkin and non-Hodgkin lymphoma. It says that the relapse rate for Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL) patients are 30% and 50%. It mentions the report "Brentuximab Vedotin: First...

  • CANCER CHEMOTHERAPY: Those dreaded side effects and what to do about them. Levitt, Doreen Zeh // RN;Sep80, Vol. 43 Issue 9, p50 

    Part III. Presents information on the side effects and nursing implications of several anti-cancer agents. Bleomycin; Dactinomycin; Daunorubicin; Doxorubicin hydrochloride; Mithramycin; Mitomycin.

  • Cancer Chemotherapy Update. Solimando Jr., Dominic A.; Waddell, Aubrey // Hospital Pharmacy;Oct2009, Vol. 44 Issue 10, p858 

    The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparing, dispensing, and administering antineoplastic therapy and to the agents, commercially available and...

  • Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease. Diehl, Volker; Franklin, Jeremy; Pfreundschuh, Michael; Lathan, Bernd; Paulus, Ursula; Hasenclever, Dirk; Tesch, Hans; Herrmann, Richard; Dorken, Bernd; Müller-Hermelink, Hans-Konrad; Dühmke, Eckhardt; Loeffler, Markus // New England Journal of Medicine;6/12/2003, Vol. 348 Issue 24, p2386 

    Background: Faced with unsatisfactory results of treatment for advanced Hodgkin's disease, we investigated three combinations of chemotherapy. Methods: From 1993 to 1998, 1201 eligible patients 15 to 65 years of age who had newly diagnosed Hodgkin's disease in unfavorable stage IIB or IIIA or...

  • Involved-Field Radiotherapy for Advanced Hodgkin's Lymphoma. Aleman, Berthe M.P.; Raemaekers, John M.M.; Tirelli, Umberto; Bortolus, Roberto; van 't Veer, Mars B.; Lybeert, Marnix L.M.; Keuning, Jo J.; Carde, Patrice; Girinsky, Théodore; van der Maazen, Richard W.M.; Tomšič, Radka; Vovk, Marjeta; van Hoof, Achilles; Demeestere, Geertrui; Lugtenburg, Pieternella J.; Thomas, José; Schroyens, Wilfried; De Boeck, Koenraad; Baars, Johanna W.; Kluin-Nelemans, Johanna C. // New England Journal of Medicine;6/12/2003, Vol. 348 Issue 24, p2396 

    Background: The use of involved-field radiotherapy after chemotherapy for advanced Hodgkin's lymphoma is controversial. Methods: We randomly assigned patients with previously untreated stage III or IV Hodgkin's lymphoma who were in complete remission after hybrid chemotherapy with...

  • Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report. Hughes, Caren L.; Yorio, Jeffrey T.; Kovitz, Craig; Oki, Yasuhiro // Journal of Medical Case Reports;2014, Vol. 8 Issue 1, p567 

    Introduction Guillain-Barre syndrome, or acute inflammatory demyelinating polyneuropathy, has been described in the presence of malignancies such as lymphoma. Guillain-Barre syndrome/acute inflammatory demyelinating polyneuropathy causes paresthesias and weakness, which can make the treatment of...

  • Bleomycin.  // Reactions Weekly;Jul2014, Vol. 1509 Issue 1, p10 

    The article presents a case study of a 36-year-old woman who was diagnosed with flagellate dermatitis after being medicated with bleomycin for Hodgkin's lymphoma.

  • Bleomycin.  // Reactions Weekly;Aug2015, Vol. 1564 Issue 1, p37 

    The article presents a case study of a patient who developed fatal lung toxicity while receiving bleomycin for advanced Hodgkin lymphoma.

  • Antineoplastics.  // Reactions Weekly;Dec2015, Vol. 1580 Issue 1, p38 

    The article describes the case of a patient who developed febrile neutropenia after being treated for Hodgkin lymphoma with doxorubicin, bleomycin, vinblastine and dacarbazine.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics